Experimental Glioblastoma Vaccine Shows Promise in Slowing Brain Tumor Growth
In clinical trials, 97% of patients receiving a new glioblastoma vaccine did not experience tumor progression in the six months following treatment. Learn more ...
Cleveland Clinic
Better experimental models to help drugs succeed in clinical trials
Dr Amanda Swain leads the ICR's Tumour Profiling Unit, which is a state-of-the-art centre designed to accelerate progress towards precision medicine. Dr Swain ...
The Institute of Cancer Research, London
Is Cancer Immunotherapy Given in Combination with Other Treatments? Ask a Scientist
Jeffrey Weber, M.D., Ph.D., answered pressing questions from patients about combination therapy. For more ...
Cancer Research Institute
Circulating tumour cells and biomarkers - Cancer Research UK
Professor Caroline Dive leads the Clinical and Experimental Pharmacology Group at the Cancer Research UK Paterson Institute for Cancer Research in ...
Cancer Research UK
Cancer Research Institute video: Redefining "Cure"
Redefining "Cure": How Science Is Reshaping Our Perception of Cancer and How to Treat It Many cancer charities today say they're working toward finding "the ...
Cancer Research Institute
New CAR T-cell therapy gives patient hope and more | UCLA Health
Denise Delatorre was the first person to receive CAR T cell therapy at UCLA and the then-experimental cancer treatment eliminated all traces of non-Hodgkin's ...
UCLA Health
IPPCR 2015: Overview of Clinical Study Design
IPPCR 2015: Overview of Clinical Study Design Air date: Tuesday, October 20, 2015, 5:00:00 PM Category: IPPCR Runtime: 01:29:48 Description: The ...
NIH VideoCast
When Should I Ask About Immunotherapy Trials for Glioblastoma? Ask a Scientist
Dr. David Reardon of Dana-Farber Cancer Institute answers questions from our patient community about cancer immunotherapy clinical trials for brain cancer.
Cancer Research Institute
Randomization in Clinical Trials
In some phase 2 and all phase 3 clinical trials, patients are assigned to groups that receive different treatments. The process of assigning patients to these ...
National Cancer Institute
Cancer Immunotherapy: Rikki Rockett's Story
The band Poison's co-founder and drummer, Rikki Rockett, was diagnosed with oral cancer more than a year ago. When chemotherapy and radiation treatment ...
UC San Diego Health
Immunotherapy and Clinical Trials for Brain Tumors - Linda Liau, MD, PhD, MBA | UCLA Neurosurgery
Dr. Linda Liau presents Immunotherapy and Clinical Trials for Brain Tumors at the UCLA Neurosurgery Update 2019 on March 1-2, 2019. UCLA Neurosurgery ...
UCLA Health
Starting a New Day After Multiple Cancers: Shirley's Immunotherapy Story
Shirley Dumont of Southgate, Michigan, has had cancer more times than she can count. #PatientStories #CIM16 It started with breast cancer when she was just ...
Cancer Research Institute
What does “randomized”, “standard of care arm” and “experimental arm” mean in a clinical trial?
Physicians explain what randomization, standard of care arm and experimental arm mean in clinical trial study design. Randomization is where participants are ...
ThePancreasPatient
Talking to Your Oncologist about Cancer Immunotherapy
When do most patients first learn about immunotherapy? How long can you start after your initial course of treatment? How does it feel to take part in a clinical ...
Cancer Research Institute
Cancer: Who Lives? Who dies? | Ted Goldstein Ph.D. | TEDxSanFrancisco
Ted Goldstein is a Silicon Valley tech executive turned cancer researcher. After a successful career and an instrumental role as top executive at Apple, Ted ...
TEDx Talks
What is a randomised trial?
To find out more about clinical trials visit http://www.cancerresearchuk.org/about-cancer/trials/ Find out how and why researchers use randomisation to test new ...
Cancer Research UK
Gastric Cancer
Universitaetsspital Zuerich
The Latest in Lung Cancer Treatment
From radiation to immunotherapy to clinical trials, learn more about the most current lung cancer treatments from the experts at Levine Cancer Institute.
Atrium Health
Expert Perspectives: CDK 4/6 Inhibitors for ER+ Breast Cancer: Current Data and Clinical Use
Cyclin-dependent kinase (CDK) 4/6 inhibitors in combination with antiestrogen therapy work to combat endocrine resistance in women with estrogen ER+ ...
ImedexCME
Experimental Drug Shows New Promise for Advanced Melanoma Patients
Watch UCLA Jonsson Comprehensive Cancer Center researcher Antonia Ribas on KNBC Channel 4 news, in a report on an experimental drug for advanced ...
UCLA Jonsson Comprehensive Cancer Center
New Ways Immunotherapy Targets Breast Cancer, with Silvia Formenti
October is Breast Cancer Awareness Month. In this webinar designed for patients and caregivers, Silvia Formenti, M.D., discussed current immunotherapy ...
Cancer Research Institute
Kidney Cancer and Immunotherapy: Tatiana Baker's Story
Tatiana Baker of Boynton Beach, Florida was diagnosed with advanced kidney cancer in the summer of 2014. After running out of treatment options in just a few ...
MedStar Georgetown University Hospital
New Options for Lung Cancer Therapies
Dr. Joel Neal, a Stanford Cancer Institute researcher and oncologist, discussed clinical research on lung cancer therapies with a focus on immunotherapy and ...
Stanford Health Care
This could change the way cancer is treated | The Economist
A combination of drugs, including aspirin and statins, are being tested to treat cancer and other illnesses. There is mounting clinical evidence that the ...
The Economist
Recent Advances in Cancer Treatment with Metformin
Video abstract of review paper “The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review on recent advances” published in ...
Dove Medical Press
Dr. Richard Carvajal Describes Columbia's Experimental Cancer Therapy Program
The Columbia University Medical Center's Experimental Therapeutics/ Phase 1 Program provides our cancer patients access to the most promising, innovative ...
ColumbiaDoctors
Multiple Myeloma: A patient’s perspective | Dana-Farber Cancer Institute
James Bond, diagnosed with multiple myeloma in 1992, is a “huge believer” in clinical trials. Bond and his wife, Kathleen, share their inspirational story of getting ...
Dana-Farber Cancer Institute
Turning the Tables Against Pancreatic Cancer with Immunotherapy, with Robert Vonderheide
In this webinar designed for patients and caregivers, Robert Vonderheide, M.D., D.Phil., discussed current immunotherapy treatment options for patients with ...
Cancer Research Institute
Prostate Cancer Genetics and Immunotherapy in Prostate Cancer Treatment
NYU Langone medical oncologist Dr. David Wise discusses immunotherapy and genetically targeted therapies in prostate cancer treatment. Learn more about ...
NYU Langone Health
Ishwaria Subbiah on Elderly Patients Enrolling in Clinical Trials
Ishwaria Mohan Subbiah, MD, MD Anderson Cancer Center, discusses the importance of elderly patients enrolling in clinical trials.
OncLiveTV
Which Cancers Can Be Treated With Immunotherapy? Ask a Scientist
Jeffrey Weber, M.D., Ph.D., discusses immunotherapy as a treatment option for all cancer types. For more ...
Cancer Research Institute
A vaccine to personalize colorectal cancer treatment
MD Anderson researchers and physicians are working together to treat colorectal cancer patients using a new personalized cancer vaccine available through a ...
MD Anderson Cancer Center
Diet, Nutrition, and Cancer Survivorship | T. Colin Campbell, PhD (2007)
2007 Prostate Cancer Patient Conference Diet, Nutrition, and Cancer Survivorship T. Colin Campbell, PhD Professor Emeritus of Nutritional Biochemistry ...
Prostate Cancer Research Institute
Experimental therapeutics, Four Diamonds and THON - Penn State Children's Hospital
What are experimental therapeutics and clinical trials and what role does THON and Four Diamonds play? Valerie Brown, M.D. Ph.D. Director, Experimental ...
Penn State Health
Immunotherapy: Boosting the immune system to fight cancer
The concept of 'teaching' the immune system to recognize and destroy cancer cells is over a century old, but the development of immunotherapeutic strategies ...
nature video
Experimental Vaccine Doubles Survival for Glioblastoma Patients
CBS News Path features a brain cancer vaccine study led by UCLA Jonsson Comprehensive Cancer Center Researcher Dr. Linda Liau.
UCLA Jonsson Comprehensive Cancer Center
Brain tumor survivor's clinical trial recharges him | Dana-Farber Cancer Institute
After suffering from severe headaches, Kevin was told he had a brain tumor. Despite surgery, his stage 4 glioblastoma returned. But a clinical trial drug enabled ...
Dana-Farber Cancer Institute
Epidemiological Studies - made easy!
This video gives a simple overview of the most common types of epidemiological studies, their advantages and disadvantages. These include ecological ...
Let's Learn Public Health
Tomorrow’s Breakthroughs Today: Immunotherapy and the Cancer Research Institute
Leading scientists discuss the role that the Cancer Research Institute (CRI) has played in advancing the science of cancer immunotherapy. For more than 60 ...
Cancer Research Institute
New treatment opportunities for small cell lung cancer
In this presentation from the 18th European Congress: Perspectives in Lung Cancer, Dr. Egbert F. Smit discusses new treatment ofptions for small cell lung ...
ImedexCME
Immunotherapy and lung cancer
Immunotherapy harnesses the power of the immune system to fight cancer. In this episode of Cancer Newsline, Dr. John Heymach explains why he believes ...
MD Anderson Cancer Center
Experimental no longer: How Immunotherapy is changing cancer treatment
More cancer patients are turning to immunotherapy, despite a lack of supporting evidence. Immunotherapy boosts the immune system or helps the immune ...
CBC News: The National
![Cancer (Experimental and clinical) : Section XVI [of] Experta medica. Vol.124, №3](https://static.rusist.info/screens/003/295/321.jpg)
